Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection
NCT04519034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27628
Last updated 2021-08-03
Summary
Hypothesis: Serum Vitamin D (25(OH)D) is significantly lower in severe versus non-severe COVID-19 infections and that this is a function of ethnicity. There is an association between vitamin D status and various cytokines (pro-inflammatory molecules).
The primary objective of this research is to provide a snap shot of vitamin D status in patients from the South-East London area by age, sex, ethnicity and BMI and demonstrate ethnic differences in vitamin D status as well as its associations with severe vs non-severe COVID-19 infections.
The secondary objective is to determine if there is an association between vitamin D status and various cytokines (pro-inflammatory molecules) and severity of disease.
Conditions
- Covid19
Interventions
- OTHER
-
no intervention
There will be no intervention
Sponsors & Collaborators
-
Guy's and St Thomas' NHS Foundation Trust
lead OTHER
Principal Investigators
-
Agata Sobczynska-Malefora, PhD · GSTT NHS Trust
Eligibility
- Min Age
- 1 Year
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2021-01-30
- Completion
- 2021-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Effect of Vitamin D on Morbidity and Mortality of the COVID-19
NCT04552951 ·Status: UNKNOWN ·Phase: PHASE4
-
Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl
NCT06452082 ·Status: COMPLETED
-
Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
NCT04810949 ·Status: TERMINATED ·Phase: NA
-
The Effect of an Acute Bout of Exercise on Serum Vitamin D Concentration
NCT05214027 ·Status: COMPLETED
-
VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection
NCT04370808 ·Status: COMPLETED
-
Evaluation of the Relationship of Vitamin D and Vitamin D Binding Protein with Disease Severity in Pediatric Sars-CoV2
NCT05598957 ·Status: COMPLETED
-
Vitamin D on Prevention and Treatment of COVID-19
NCT04334005 ·Status: UNKNOWN ·Phase: NA
-
COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation
NCT05037253 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico
NCT04793243 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Levels in SARS-CoV-2: Do Current Adequacy Thresholds Reflect Clinical Risk? Insights From a Large Turkish Cohort
NCT04394390 ·Status: COMPLETED
-
Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers
NCT04535791 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamine D in Post-COVID Patients
NCT04969237 ·Status: COMPLETED
-
Severity of COVID-19 and Vitamin D Supplementation
NCT05166005 ·Status: UNKNOWN ·Phase: PHASE4
-
High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study
NCT04525820 ·Status: COMPLETED ·Phase: NA
-
COVID-19 and Vitamin D: Length of Hospital Stay and Mortality
NCT05221983 ·Status: COMPLETED
-
Vitamin D Supplementation and Immunity/Physical Performance
NCT03132103 ·Status: UNKNOWN ·Phase: NA
-
Determination of Vitamin D Dose to Maintain Sufficiency Amongst Indian and Malay Women in the Tropics
NCT02389179 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune Function
NCT02091219 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Covid-19 and Vitamin D in Nursing-home
NCT04435119 ·Status: COMPLETED
-
Getting Vitamin D Dosing Right
NCT02474446 ·Status: COMPLETED ·Phase: NA
-
Vitamin D and Health Status of British African-Caribbean Women
NCT04179370 ·Status: RECRUITING
-
Tele-health Enabled Clinical Trial for COVID-19
NCT04489628 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Vitamin D Supplementation and Clinical Outcomes in Severe COVID-19 Patients
NCT05384574 ·Status: UNKNOWN ·Phase: NA
-
Vitamin D and COVID-19 Management
NCT04385940 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamin D Testing and Treatment for COVID 19
NCT04407286 ·Status: COMPLETED ·Phase: PHASE1